Costly Drug for Fatal Muscular Disease Wins F.D.A. Approval
Spinraza, a “life-changing” drug for spinal muscular atrophy, will cost as much as $750,000 for the first year of treatment and $375,000 annually after that. [Source]
Publication Date:Origin: nytimes.com
Category: Drugs (Pharmaceuticals)
Topics: annually, treatment, first, atrophy, muscular, spinal, “life-changing”, Spinraza, Approval, Disease, Muscular, Fatal, Costly
Source: http://www.nytimes.com/2016/12/30/business/spinraza-price.html?partner=rss&emc=rss